Protocolo de tratamiento del asma

  1. Armentia Medina, A. 1
  2. Martín Armentia, S. 2
  3. Fernández Cortés, S. 3
  1. 1 Unidades de Alergia, Hospital Universitario Río Hortega, Valladolid, España
  2. 2 Unidades de Pediatría, Centro Delicias, Valladolid, España
  3. 3 Unidades de Asma Difícil, Hospital Universitario Río Hortega, Valladolid, España
Mostrar afiliaciones +
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2021

Título del ejemplar: Enfermedades del sistema inmune (I)Enfermedades alérgicas

Serie: 13

Número: 28

Páginas: 1588-1592

Tipo: Artículo

DOI: 10.1016/J.MED.2021.03.015 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Objetivos de desarrollo sostenible

Resumen

Asthma treatment must be comprehensive and must consider the following four basic pillars: pharmacological treatment, allergen avoidance measures, allergen immunotherapy, and health education. Acute asthma attack is treated with rapid-acting bronchodilators together with inhaled corticosteroids and, only in some cases, systemic corticosteroids. Biological drugs will be used if improvement is not achieved or in severe eosinophilic asthma. Inhalation devices are essential to make the use of drugs profitable; in children, they must be adapted to the age and clinical situations. Maintenance treatment requires both proper diagnosis of type of asthma and periodic monitoring of therapeutic drug effect. Drugs to prevent are: antileukotrienes, inhaled corticosteroids, long-acting beta 2 stimulants and, in severe forms, monoclonal anti-IgE antibodies. Immunotherapy against allergens, very effective in pediatrics, has precise indications.

Referencias bibliográficas

  • Azmeh R, Greydanus DE, Agana MG, Dickson CA, Patel DR, Ischander MM, Update in pediatric asthma: selected issues. Dis Mon. 2020;66(4):100886.
  • GEMA4.4. Guía española para el manejo del asma © 2019. Comité Ejecutivo de la GEMA.
  • GINA 2020. Global strategy for asthma management and prevention.
  • Schmitt J, Wüstenberg E, Küster D, Mücke V, Serup Hansen N, Tesch F. The moderating role of allergy immunotherapy in asthma progression: Results of a population bases cohort study. Allergy. 2020;75(3):596-602.
  • Zaidan MF, Ameredes BT, Calhoun WJ. Management of acute asthma in adults in 2020. JAMA. 2020;323(6):563-4
Fuente de los datos: Dialnet